How big is the Whole Exome Sequencing Market?

The Whole Exome Sequencing Market size is expected to reach USD 1.99 billion in 2024 and grow at a CAGR of 17.89% to reach USD 4.53 billion by 2029. Read More

What is the current Whole Exome Sequencing Market size?

In 2024, the Whole Exome Sequencing Market size is expected to reach USD 1.99 billion. Read More

Who are the key players in Whole Exome Sequencing Market?

Bio-Rad Laboratories Inc., Eurofins Scientific Group, F. Hoffmann-La Roche AG, Illumina Inc. and Thermo Fisher Scientific Inc. are the major companies operating in the Whole Exome Sequencing Market. Read More

Which is the fastest growing region in Whole Exome Sequencing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Whole Exome Sequencing Market?

In 2024, the North America accounts for the largest market share in Whole Exome Sequencing Market. Read More

What years does this Whole Exome Sequencing Market cover, and what was the market size in 2023?

In 2023, the Whole Exome Sequencing Market size was estimated at USD 1.63 billion. The report covers the Whole Exome Sequencing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Whole Exome Sequencing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Whole Exome Sequencing Market Share

Statistics for the 2023 & 2024 Whole Exome Sequencing market share, created by Mordor Intelligence™ Industry Reports. Whole Exome Sequencing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Whole Exome Sequencing Industry

The whole exome sequencing market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international and domestic companies that hold market shares and are well known, including Eurofins Scientific Group, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, illumine Inc., and Thermo Fisher Scientific Inc. Konica Minolta Inc. (Ambry Genetics), Beijing Genomics Institute, Azenta Inc., Psomagen Inc. (Macrogen Inc.), PerkinElmer Inc., GENEYX GENOMEX, and CD Genomics, QIAGEN Inc.